431
Views
11
CrossRef citations to date
0
Altmetric
Review

Current aproach to cancer pain management: Availability and implications of different treatment options

&
Pages 381-400 | Published online: 28 Dec 2022

References

  • AhmedzaiSNew approaches to pain control in patients with cancerEur J Can199733Suppl 6S814
  • AhmedzaiSBrooksDTransdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of lifeJ Pain Symptom Manage199713254619185430
  • AlvarezVArttamangkulSWilliamsJTA RAVE about opioid withdrawalNeuron2001327616311738021
  • [ACS] American Cancer SocietyCancer facts and figures 2002 [online]2002 Accessed 4 April 2006. URL: http://www.cancer.org/docroot/STT/STT_0.asp
  • ArnoldLLuYCroffordLA double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorderArthritis Rheum20045029748415457467
  • BackonjaMMAnticonvulsants (antineuropathics) for neuropathic pain syndromesClin J Pain200016Suppl 66772
  • BalducciLManagement of cancer pain in geriatric patientsJ Support Oncol200311759115334874
  • BallantyneJCMaoJOpioid therapy for chronic painN Engl J Med200334919435314614170
  • BeckerRJakobDUhleEThe significance of intrathecal opioid therapy for the treatment of neuropathic cancer pain conditionsStereotact Funct Neurosurg200075162611416261
  • BedderMDBurchielKLarsonACost analysis of two implantable narcotic delivery systemsJ Pain Symptom Manage19916368731908884
  • BenedettiCBrockCCleelandCNCCN practice guidelines for cancer painOncology2000141355011195407
  • BerlandDPain management in patients with advanced cancerAnn Intern Med200013259310744602
  • BloodworthDIssues in opioid managementAm J Phys Med Rehabil200584Suppl 3S425515722783
  • BombardierCLaineLReicinAComparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritisNew Eng J Med200034315202811087881
  • BrueraEMacmillanKHansonJThe cognitive effects of the administration of narcotic analgesics in patients with cancer painPain19893913162812850
  • BuddKBuprenorphine and the transdermal system: the ideal match in pain managementInt J Clin Pract Suppl200313391412665118
  • BurtonAWDriverLCMendozaTROral transmucosal fentanyl citrate in the outpatient management of severe cancer pain crisesClin J Pain2004a201959715100597
  • BurtonAWRajagopalAShahHNEpidural and intrathecal analgesia is effective in treating refractory cancer painPain Med2004b52394715367301
  • CaraceniAZeccaEBonezziCGabapentin for neuropathic cancer pain: a randomized controlled trial from the Gabapentin Cancer Pain Study GroupJ Clin Oncol20042229091715254060
  • CaraceniAZeccaEMartiniCGabapentin as an adjuvant to opioid analgesia for neuropathic cancer painJ Pain Symptom Manage1999174414510388250
  • CarrDBGoudasLCBalkEMEvidence report on the treatment of pain in cancer patientsJ Nat Cancer Inst Monogri2004322331
  • ChapmanSLByas-SmithMGReedBAEffects of intermediate- and long-term use of opioids on cognition in patients with chronic painClin J Pain200218Suppl 4S839012479258
  • ChernyNJThe management of cancer painCA Cancer J Clin2000507011610870487
  • CollinsSLMooreRAMcQuayHJAntidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic reviewJ Pain Symptom Manage2000204495811131263
  • ColuzziPHSchwartzbergLConroyJDBreakthrough cancer pain: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulfate immediate release (MSIR)Pain2001911233011240084
  • DalalSMelzackRPotentiation of opioid analgesia by psychostimulant drugs: a reviewJ Pain Symptom Manage199816245539803052
  • DavisMPWalshDMethadone for relief of cancer pain: a review of pharmacokinetics, pharmacodynamics, drug interactions and protocols of administrationSupport Care Cancer20019738311305074
  • DesmeulesJAPiguetVCollartLContribution of monoaminergic modulation to the analgesic effect of tramadolBr J Clin Pharmacol1996417128824687
  • DewsTEMekhailNSafe use of opioids in chronic noncancer painCleve Clin J Med20047189790415570739
  • DoggrellSAIntrathecal ziconotide for refractory painExpert Opin Investig Drugs20041387577
  • DonnelySDavisMPWalshDMorphine in cancer pain management: a practical guideSupport Care Cancer200210133511777184
  • DonnerBZenzMStrumpfMLong-term treatment of cancer pain with transdermal fentanylJ Pain Symptom Manage199815168759564118
  • DunnMJNonsteroidal anti-inflammatory drugs and renal functionAnn Rev Med198435411286426373
  • DuntemanEDLevetiracetam as an adjunctive analgesic in neoplastic plexopathies: case series and commentaryJ Pain Palliat Care Pharmacother200519354315814513
  • DworkinRHBackonjaMRowbothamMCAdvances in neuropathic pain: diagnosis mechanisms and treatment recommendationsArch Neurol2003a6015243414623723
  • DworkinRHCorbinAEYoungJPPregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trialNeurology2003b6012748312707429
  • EisenachJCDu PenSDuboisMEpidural clonidine analgesia for intractable cancer pain. The Epidural Clonidine Study GroupPain199561391997478682
  • EisenbergECarrDBChalmersTCNeurolytic celiac plexus block for treatment of cancer pain: a meta-analysisAnesth Analg199580290957818115
  • ErdineSTaluGKCost effectiveness of implantable devices versus tunneled cathetersCurr Rev Pain1998215762
  • EttingerABPortenoyRKThe use of corticosteroids in the treatment of symptoms associated with cancerJ Pain Symptom Manage19883991033282015
  • EvansHCEasthopeSETransdermal buprenotphineDrugs2003631999201012962515
  • FarrWCThe use of corticosteroids for symptom management in terminally ill patientsAm J Hosp Care1990741462361097
  • FarrarJTClearyJRauckROral transmucosal fentanyl citrate: randomized, double blind placebo controlled trial for treatment of breakthrough pain in cancer patientsAnesth Analg19988973238
  • FenstermakerRANeurosurgical invasive techniques for cancer pain: a pain specialist’s viewCurr Pain Headache Rep1999619097
  • FinchPMRobertsLJPriceLHypogonadism in patients treated with intrathecal morphineClin J Pain2000162515411014399
  • FinePGBuschMACharacterization of breakthrough pain by hospice patients and their caregiversJ Pain Symptom Manage199816179839769620
  • FourneyDRSchomerDFNaderRPercutaneous vertebroplasty and kyphoplasty for painful vertebral body fractures in cancer patientsJ Neurosurg200398Suppl 1213012546384
  • FriedmanLLRodgersPEPain management in palliative careClin Fam Pract20046371
  • FukshanskyMAreMBurtonAWThe role of opioids in cancer pain managementPain Practice20055435417156116
  • GatscherSBeckerRUhleECombined intrathecal baclofen and morphine infusion for the treatment of spasticity related pain and central deafferentation painActa Neurochir Suppl (Wien)2002797576
  • Gilmer-HillHSBogganJESmithKAIntrathecal morphine delivered via subcutaneous pump for intractable cancer pain: a review of the literatureSurg Neurol19995112159952117
  • GlassmanAHBiggerJTCardiovascular effects of therapeutic doses of tricyclic antidepressants. A reviewArch Gen Psychiatr198138815207247643
  • GordonDHEfficacy and safety of intravenous bisphosphonates for patients with breast cancer metastatic to bone: a review of randomized, double-blinded, phase III trialsClin Breast Cancer200561253116001990
  • GreenbergHSKimJHPosnerJBEpidural spinal cord compression from metastatic tumor: results with a new treatment protocolAnn Neurology1980836166
  • GrondSRadbruchLMeuserTHigh-dose tramadol in comparison to low-dose morphine for cancer pain reliefJ Pain Symptom Manage1999181747910517038
  • GrondSZechDLehmannKTransdermal fentanyl in the long-term treatment of cancer pain: a prospective study of 50 patients with advanced cancer of the gastrointestinal tract or the head and neck regionPain199769191989060030
  • GutsteinHBAkilHHardmanJGLimbridEOpioid analgesicsGoodman and Gilman’s the Pharmacological Basis of Therapeutics200110New YorkMcGraw-Hill Professional569619
  • HaegerstamGATPathophysiology of bone pain: A reviewActa Orthop Scand2001723081711480611
  • HagenNAThirlwellMEisenhofferJEfficacy, safety, and steady-state pharmacokinetics of once-a-day controlled-release morphine (MSContinXL) in cancer painJ Pain Symptom Manage200529809015652441
  • HaratiYGoochCSwensonMDouble-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathyNeurology1998501842469633738
  • HassenbuschSJGunesSWachsmanSIntrathecal clonidine in the treatment of intractable pain: a phase I/II studyPain Med20023859115102154
  • HeiskanenTERuismakiPMSeppalaTAMorphine or oxycodone in cancer pain?Acta Oncologica2000399414711207001
  • van HiltenBJvan de BeekWJHoffJIIntrathecal baclofen for the treatment of dystonia in patients with reflex sympathetic dystrophyN Engl J Med20003436253010965009
  • HockingGCousinsMJKetamine in chronic pain management: an evidence-based reviewAnesth Analg20039717303914633551
  • JacoxACarrDBPayneRClinical practice guideline #9: Management of cancer pain [online](Publication #94-0592). AHCPR (Agency for Health Care Policy and Research)1994Washington DCDept of Health and Human Services Accessed 2 April 2006. URL: http://www.ahrq.gov/clinic/cpgarchv.htm
  • JemalATiwariRCMurrayTCancer Statistics, 2004CA Cancer J Clin20045482914974761
  • JensenTSAnticonvulsants in neuropathic pain: rationale and clinical evidenceEur J Pain20026A61811888243
  • JonesBFinlayIRayAIs there still a role for open cordotomy in cancer pain management?J Pain Symptom Manage2003251798412590033
  • KannanTRSaxenaABhatnagarSOral ketamine as an adjuvant to oral morphine for neuropathic pain in cancer patientsJ Pain Symptom Manage20022360511779670
  • KanpolatYCaglarSAkyarSCT-guided pain procedures for intractable pain in malignancyActa Neurochir Suppl (Wien)1995648891
  • KaoLWAminYKirkMAIntrathecal baclofen withdrawal mimicking sepsisJ Emerg Med2003244232712745045
  • KedlayaDReynoldsLWaldmanSEpidural and intrathecal analgesia for cancer painBest Pract Res Clin Anaesthesiol2002166516512516896
  • KhojainovaNSantiago-PalmaJKornickCAOlanzapine in the management of cancer painJ Pain Symptom Manage2002233465011997204
  • KornickCASantiago-PalmaJMorylNBenefit-risk assessment of transdermal fentanyl for the treatment of chronic painDrug Safety2003269517314583070
  • KorteWStoutzNMorantRDay-to-day titration to initiate transdermal fentanyl in cancer patients: short- and long-term experience in a prospective study of 39 patientsJ Pain Symptom Manage199611139468851370
  • LawlorPGTurnerKSHansonJDose ratio between morphine and methadone in patients with cancer pain: a retrospective studyCancer1998821167739506365
  • de Leon-CasasolaOAKentELemaMJNeurolytic superior hypogastric plexus block for chronic pelvic pain associated with cancer painPain199354145518233527
  • LordonSPInterventional approach to cancer painCurr Pain Headache Rep20026202612003691
  • LussierDHuskeyAGPortenoyRKAdjuvant analgesics in cancer pain managementThe Oncologist200495719115477643
  • LussierDPappagalloM10 most commonly asked questions about the use of opioids for chronic painThe Neurologist2004102212415252358
  • LynchMAntidepressants as analgesics: a review of randomized controlled trialsJ Psychiatry Neurosci200126303611212591
  • MagniGArsieDDe LeoDAntidepressants in the treatment of cancer pain: a survey in ItalyPain198729347533614969
  • MaizelsMMcCarbergBAntidepressants and antiepileptic drugs for chronic non-cancer painAm Fam Physician2005714839015712623
  • MaoJPriceDDMayerDJThermal hyperalgesia in association with the developemnt of morphine tolerance in rats: roles of excitatory amino acid receptors and protein kinase CJ Neurosci1994562301127908958
  • MaoJPriceDDMayerDJMehcnisms of hyperalgesia and opiate tolerance: a current view of their possible interactionsPain199562259748657426
  • MasandPSGuptaSSelective serotonin-reuptake inhibitors: an updateHarvard Rev Psychiatry19995254752
  • MathurVZiconotide: a new pharmacological class of drug for the management of painSemin Anesth Periop Med Pain2000196775
  • McCarbergBHBarkinRLLong-acting opioids for chronic pain: pharmacotherapeutic opportunities to enhance compliance, quality of life, and analgesiaAm J Ther200181818611344385
  • McGivernJGMcDonoughSIVoltage-gated calcium channels as targets for the treatment of chronic painCurr Drug Targets CNS Neurol Disord200434577815578964
  • MeldrumMThe ladder and the clock: cancer pain and public policy at the end of the twentieth centuryJ Pain Symptom Manage200529415415652438
  • MercandanteSCasuccioAGenoveseGIneffectiveness of dextromethorphan in cancer painJ Pain Symptom Manage199816317229846026
  • MercadanteSOpioid rotation for cancer pain: rationale and clinical aspectsCancer1999a8618566610547561
  • MercadanteSNeuraxial techniques for cancer pain: an opinion about unresolved therapeutic dilemmasReg Anesth Pain Med1999b2474839952099
  • MercadanteSArcuriETirelliWAnalgesic effects of intravenous ketamine in cancer patients on morphine therapy: a randomized controlled, double-blind, crossover, double-dose studyJ Pain Symptom Manage2000202465211027905
  • MercadanteSFulfaroFCasuccioAThe use of corticosteroids in home palliative careSupport Care Cancer200193868911497394
  • MerckMerck announces voluntary worldwide withdrawal of VIOXX®. News release [online]2004 Accessed 2 April 2006. URL: http://www.vioxx.com/vioxx/documents/english/vioxx_press_release.pdf
  • MiguelRInterventional treatment of cancer pain: the fourth step in the World Health Organization analgesic ladder?Cancer Control200071495610783819
  • MiljanichGPZiconotide: neuronal calcium channel blocker for treating severe chronic painCurr Med Chem20041130294015578997
  • MiljanichGPRamachandranJAntagonists of neuronal calcium channels: structure, function, and therapeutic implicationsAnnu Rev Pharmacol Toxicol199535707347598513
  • MohammedIHussainAIntrathecal baclofen withdrawal syndrome- a life-threatening complication of baclofen pump: A case reportBMC Clin Pharmacol200441515028124
  • MoralesEMucksavageJJCyclooxygenase-2 inhibitor-associated acute renal failure: case report with rofecoxib and review of the literaturePharmacotherapy20022213172112389882
  • MukherjeeDNissenSETopolEJRisk of cardiovascular events associated with selective COX-2 inhibitorsJAMA20012869545911509060
  • NautaHJSoukupVMFabianRHPunctate midline myelotomy for the relief of visceral cancer painJ Neurosurg200092Suppl 21253010763680
  • [NCCN] National Comprehensive Cancer NetworkCancer pain treatment guidelines for patients (version II) [online]2005 Accessed 4 April 2006. URL: http://www.nccn.org/patients/patient_gls.asp
  • NedeljkovicSSWasanAJamisonRNAssessment of efficacy of long-term opioid therapy in pain patients with substance abuse potentialClin J Pain200218Suppl 4S395112479253
  • NobleBClarkDMeldrumMThe measurement of pain, 1945–2000J Pain Symptom Manage200529142115652435
  • OneschukDal-ShahriMZThe pattern of gabapentin use in a tertiary palliative care unitJ Palliat Care20031951858714606330
  • OnghenaPvan HoudenhoveBAntidepressant-induced analgesia in chronic non-malignant pain: a meta-analysis of 39 placebo-controlled studiesPain199249205191535121
  • PanchalSJAnghelescuDLBenedettiCAdult cancer pain. Clinical Practice Guidelines in Oncology (version 2.2005) [online]National Comprehensive Cancer Network2005 Accessed 6 April 2006. URL: http://www.nccn.org/professionals/cms/pdf/pain.pdf
  • PayneRMathiasSDPastaDJQuality of life and cancer pain: satisfaction and side effects with transdermal fentanyl versus oral morphineJ Clin Oncol1998161588939552070
  • PereiraJLawlorPViganoAEquianalgesic dose ratios for opioids: a critical review and proposals for long-term dosingJ Pain Symptom Manage2001226728711495714
  • PharoGHZhouLPharmacologic Management of Cancer PainJAOA2005105S212816368904
  • PlancarteRde Leon-CasasolaOAEl-HelayMNeurolytic superior hypogastric plexus block for chronic pelvic pain associated with cancerReg Anesth199722562689425974
  • PortenoyRKOpioid therapy for chronic nonmalignant pain: A review of the critical issuesJ Pain Symptom Manage199611203178869456
  • PortenoyRKHagenNABreakthrough pain: definition, prevalence and characteristicsPain199041273821697056
  • PriceMJLevetiracetam in the treatment of neuropathic pain: three case studiesClin J Pain200420333614668654
  • PudDEisenbergESpitzerAThe NMDA receptor antagonist amantadine reduces surgical neuropathic pain in cancer patients: a double blind, randomized, placebo-controlled trialPain199875349549583771
  • RadbruchLSabatowskiRPetzkeFTransdermal fentanyl for the management of cancer pain: a survey of 1005 patientsPalliat Med2001153092112054148
  • RaffaRBPharmacology of oral combination analgesics: rational therapy for painJ Clin Pharm Ther2001262576411493367
  • RaffaRBFriderichsEReimannWOpioid and nonopioid components independently contribute to the mechanism of action of tramadol, an ‘atypical’ opioid analgesicJ Pharmacol Exp Ther1992260275851309873
  • RauckRLCherryDBoyerMFLong-term intrathecal opioid therapy with a patient-activated implanted delivery system for the treatment of refractory cancer painJ Pain200344414714622664
  • RiceASMatonSGabapentin in postherpetic neuralgia: a randomized, double blind, placebo-controlled studyPain2001942152411690735
  • RigoliGTerriniGCordioliZIntrathecal baclofen withdrawal syndrome caused by low residual volume in the pump reservoir: A report of 2 casesArch Phys Med Rehabil8520646615605349
  • RipamontiCGroffLBrunelliCSwitching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio?J Clin Oncol1998163216219779694
  • RosenLSGordonDKaminskiMZoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trialCancer J200173778711693896
  • RothAKolaricKAnalgesic activity of calcitonin in patients with painful osteolytic metastases of breast cancer: results of a controlled randomized studyOncology198643283873531953
  • RouffGLemaMStrategies in pain management: new and potential indications for COX-2 specific inhibitorsJ Pain Symptom Manage200325Suppl 2S213112604154
  • RowbothamMHardenNStaceyBGabapentin for the treatment of postherpetic neuralgia: a randomized controlled trialJAMA19982801837429846778
  • RozansMDreisbachALertoraJJPalliative uses of methylphenidate in patients with cancer: a reviewJ Clin Oncol2002203353911773187
  • RussellIJKaminMBennettRMEficacy of tramadol in treatment of pain in fbromyalgiaJ Clin Rheumatol200062505719078481
  • SaartoTWiffenPJAntidepressants for neuropathic painCochrane Database Syst Rev20053CD00545416034979
  • SarhillNWalshDNelsonKAHydromorphone: pharmacology and clinical applications in cancer patientsSupport Care Cancer20019849611305075
  • SchugSAZechDDorrUCancer pain management according to WHO analgesic guidelinesJ Pain Symptom Manage1990527322324558
  • SerafiniANTherapy of metastatic bone painJ Nucl Med20014289590611390554
  • ShahHNBurtonAWMendozaTNeurolytic blockade of the splanchnic nerves block relieves refractory pain associated with upper abdominal malignancy2003Annual Meeting of the American Society of AnesthesiologistsOctober 11–15San Francisco California Abstract A1024
  • SindrupSHBachFWMadsenCVenlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trialNeurology20036012848912707430
  • SindrupSHBjerreUDejgaardAThe selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathyClin Pharmacol Ther199252547521424428
  • SindrupSHGramLFBrosenKThe selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptomsPain199042135442147235
  • SinghDMerck withdraws arthritis drug worldwideBMJ200432981615472245
  • SkaerTLPractice guidelines for transdermal opioids in malignant painDrugs20046426293815537367
  • SlavinKVHsuFPKFesslerRGBurchielKJIntrathecal opioids: intrathecal drug-delivery systemsSurgical management of pain2002New YorkThieme60313
  • SlavinKVSolkoAMSchulderIntrathecal narcotics: spinal and intraventricularHandbook of stereotactic and functional neurosurgery2003New YorkMarcel Dekker44357
  • SlavinKVTesoroEPMucksavageJJThe treatment of cancer painDrugs Today (Barc.)2004402354515148532
  • SmithTJStaatsPSDeerTRandomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survivalJ Clin Oncol20022040404912351602
  • StaatsPSYearwoodTCharapataSIntrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDSJAMA2004291637014709577
  • SzantoJAdyNJozsefSPain killing with calcitonin nasal spray in patients with malignant tumorsOncology199249180821495743
  • TaubESpinal cord stimulation for cancer-related pain: a neglected indication?2003Quadrennial Meeting Am Soc Stereotactic Funct NeurosurgMay 18–21New York Abstract 52
  • Tremont-LukatsIWMegeffCBackonjaMMAnticonvulsants for neuropathic pain syndromes: mechanism of action and place in therapyDrugs20006010295211129121
  • TrujilloKAAkilHInhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801Science19912518571824728
  • TurkDCMonarchESWilliamsADCancer patients in pain: considerations for assessing the whole personHematol Oncol Clin North Am2002165112512170565
  • ValdimarsdottirUHelgasonARFurstCJThe unrecognized cost of cancer patients’ unrelieved symptoms: a nationwide follow-up of their surviving partnersBr J Cancer20028615404512085201
  • VarvelJRShaferSLHwangSSAbsorption characteristics of transdermally administered fentanylAnesthesiology198970928342729633
  • VestergaardKAndersenGGottrupHLamotrigine for central poststroke pain: a randomized controlled trialNeurology2001561849011160953
  • VielhaberAPortenoyRKAdvances in cancer pain managementHematol Oncol Clin North Am2002165274112170566
  • WalshTDControlled study of imipramine and morphine in chronic pain due to advanced cancerProc Am Soc Clin Oncol19865237
  • WatanabeSBrueraECorticosteroids as adjuvant analgesicsJ Pain Symptom Manage19949442457822883
  • WatsonCPThe treatment of neuropathic pain: antidepressants and opioidsClin J Pain200016Suppl 24955
  • WebsterLHendersonRKatzNCharacterization of confusion, an adverse event associated with intrathecal ziconotide infusion in chronic pain patientsPain Med200122535415102228
  • WeinbroumAABenderBNirkinADextromethorphan-associated epidural patient-controlled analgesia provides better pain- and analgesics-sparing effects than dextromethorphan-associated intravenous patient-controlled analgesia after bone-malignancy resection: a randomized, placebo-controlled, double-blinded studyAnesth Analg2004987142214980926
  • WermelingDDrassMEllisDPharmacokinetics and pharmacodynamics of intrathecal ziconotide in chronic pain patientsJ Clin Pharmacol2003436243612817525
  • WhittleIRJenkinsonJLCT-guided stereotactic antero-medial pulvinotomy and centromedian-parafascicular thalamotomy for intractable malignant painBr J Neurosurg199591952007632366
  • WilsonPRCaplanRAConnisRTPractice guidelines for chronic pain management: a report by the American Society of Anesthesiologists Task Force on Pain Management, Chronic Pain SectionAnesthesiology19978699510049105246
  • WinslowMSeymourJClarkDStories of cancer pain: a historical perspectiveJ Pain Symptom Manage200529223115652436
  • WongDLBakerCMPain in children: comparison of assessment scalesPediatr Nurs1988149173344163
  • WongETGunesSGuaghanEPalliation of intractable cancer pain by MRI-guided cingulotomyClin J Pain199713260639303260
  • YajnikSSinghGPSinghGPhenytoin as a coanalgesic in cancer painJ Pain Symptom Manage19927209301517643
  • ZakrzewskaJMChaudhryZNurmikkoTJLamotrigine (lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trialPain199773223309415509
  • ZechDFGrondSLynchJValidation of World Health Organization guidelines for cancer pain relief: a 10-year prospective studyPain19956365768577492